In epithelial ovarian cancer, miR-130b inhibited cancer cell migration and invasion via TGF-β signaling (Zhou et al., 2017), and in nasopharyngeal carcinoma, miR-130a promoted apoptosis by targeting BACH2 (Chen et al., 2017). This evidence concerns the gene BACH2 and ovarian carcinoma.